Mr. Anderson has developed a unique turnaround strategy for Bayer, whose stock price is down 50% from the year prior.
Under the plan, Mr. Anderson aims to cut costs by 2 billion euros — or $2.17 billion — and lay off an undisclosed number of managers. Over the next few years, the company will transition to operating with 5,000 to 6,000 self-directed teams, according to the report. The teams will consist of employees from various departments who will identify and collaborate on projects for 90-day cycles. After each cycle, teams will reconfigure and shift focus to new projects.
“We don’t have to be that good to beat the current system,” he told the Journal, citing the inefficiencies of modern management structures.
Mr. Anderson said he believes large companies will study Bayer’s strategy and implement their own versions in the future.
Read the full article here.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.